Midwest Cornea Associates, LLC.

Carmel, Indiana 46290

3 studies enrolling now · 8 studies all time

What they study most

Blepharitis, Corneal Scar, Dry Eye Disease, Limbal Stem Cell Deficiency, Neurotrophic Keratitis, Neurotrophic Keratopathy, Ocular Inflammation and Pain

Studies at this site

• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency — Recruiting now
• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars — Recruiting now
• Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 — Recruiting now
• A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease — Completed
• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects — Completed
• A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease — Completed
• Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis — Completed
• Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery — Completed